Device Gastroenterology

Capsocam Plus

Payments companies reported to CMS as associated with Capsocam Plus. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.5Massociated payments (2023-2025)
1,292clinicians with associated payments
1company reporting

By year

2023 $338K
2024 $16K
2025 $1.1M

Payments reported as associated with Capsocam Plus, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Gastroenterology (Internal Medicine) $1.4M
Pediatric Gastroenterology $16K
Internal Medicine $2,611
Surgery $308
Hospitalist $241
Family Medicine $237

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Capsocam Plus

These are the largest totals companies reported as associated with Capsocam Plus. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Wassem Juakiem Biloxi, MS Gastroenterology (Internal Medicine) $269,181.65
Nathan Schomaker Lone Tree, CO Gastroenterology (Internal Medicine) $240,280.96
Christopher Haydek Castle Rock, CO Gastroenterology (Internal Medicine) $101,879.83
Brian Smith Shelby, NC Gastroenterology (Internal Medicine) $92,377.50
Ian Storch New Hyde Park, NY Gastroenterology (Internal Medicine) $89,398.60
Martin Hoffman Hartford, CT Gastroenterology (Internal Medicine) $71,600.00
Walter Park Stanford, CA Gastroenterology (Internal Medicine) $56,530.82
Javier Parra Miami, FL Gastroenterology (Internal Medicine) $52,740.78
George Sanchez Miami, FL Gastroenterology (Internal Medicine) $44,076.67
Cregan Laborde Murfreesboro, TN Gastroenterology (Internal Medicine) $39,609.07

Prescribed Capsocam Plus?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.